4-(2,6-DIMETHYL-MORPHOLIN-4-YL)-BUTYLAMINE
- $309 - $777.32
- Product name: 4-(2,6-DIMETHYL-MORPHOLIN-4-YL)-BUTYLAMINE
- CAS: 876716-85-7
- MF: C10H22N2O
- MW: 186.29
- EINECS:
- MDL Number:MFCD07801134
- Synonyms:TIMTEC-BB SBB010750;ASINEX-REAG BAS 10151009;4-(2,6-DIMETHYL-MORPHOLIN-4-YL)-BUTYLAMINE;4-Morpholinebutanamine, 2,6-dimethyl-
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
- Oakwood
Package
- 500MG
- 1g
- ManufacturerAK Scientific
- Product number1356AF
- Product description4-(2,6-Dimethyl-morpholin-4-yl)-butylamine
- Packaging1g
- Price$467
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0144905
- Product description4-(2,6-DIMETHYLMORPHOLIN-4-YL)BUTAN-1-AMINE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number020290
- Product description4-(2,6-Dimethyl-morpholin-4-yl)-butylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
- ManufacturerOakwood
- Product number059086
- Product description4-(2,6-Dimethyl-morpholin-4-yl)-butylamine
- Packaging1g
- Price$309
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 1356AF | 4-(2,6-Dimethyl-morpholin-4-yl)-butylamine | 1g | $467 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0144905 | 4-(2,6-DIMETHYLMORPHOLIN-4-YL)BUTAN-1-AMINE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Matrix Scientific | 020290 | 4-(2,6-Dimethyl-morpholin-4-yl)-butylamine | 1g | $378 | 2021-12-16 | Buy |
Oakwood | 059086 | 4-(2,6-Dimethyl-morpholin-4-yl)-butylamine | 1g | $309 | 2021-12-16 | Buy |
Properties
Boiling point :265.7±25.0 °C(Predicted)
Density :0.918±0.06 g/cm3(Predicted)
pka :10.53±0.10(Predicted)
Density :0.918±0.06 g/cm3(Predicted)
pka :10.53±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|